regenold GmbH
  • Solutions
    • By Product Type:

      • Pharmaceuticals
      • Biologicals, Biosimilars & ATMPs
      • Medical Devices
      • In Vitro & Companion Diagnostics
      • Digital Health & SaMD
      • Combination Products
      • Borderline Products
      • Food & Cosmetics

      Keep Your Drug-Device Combination Products Variation-Ready

      We’ve experienced, that even long established drug–device combinations can fall short of current regulatory data expectations—putting variations at risk. We support you in assessing and strengthening your DDC data package to ensure robust, compliant submissions.

      DDC Variation Readiness

      EU Submission Readiness for Global Pharma

      Avoid Late Surprises in Your EU Submission. FDA approval is not a guarantee of EU readiness. European regulators apply different expectations for data, documentation, and operational infrastructure. Many US companies encounter gaps that lead to delays, rework, or regulatory friction.

      EU Readiness Checks

      SPOTLIGHT: EU AI Act Q&A Competition

      From May to June 2026, we are hosting the first competition to assess the ability of AI agents to answer truthfully, concisely, and effectively to questions of the AI Act.

      AI Act Competition
  • Services
    • Regulatory Affairs:

      • Regulatory Strategy & Operations
      • Regulatory Intelligence
      • Medical Device & IVD Regulatory Services
      • Software as a Medical Device & Cybersecurity
      • Product Information, Labelling & Promotional Compliance
      • Regulatory Compliance Roles & Legal Representation

      Development & Science:

      • Preclinical Development
      • Pharmaceutical Development & CMC
      • Clinical Development
      • Medical & Scientific Writing

      Quality, Compliance, & Data:

      • Quality & Compliance
      • Risk Management & Human Factors
      • AI Governance & Compliance
      • Data Protection & Information Security

      Pharmacovigilance & Safety:

      • Pharmacovigilance & Device Vigilance

      Commercial & Lifecycle:

      • Market Access & HTA Strategy
      • Post-Approval & Lifecycle Management
      • Due Diligence Support

      Strategic Advisory:

      • Strategic Advice
  • Focus Areas
    • Focus Areas:

      • Pharmaceutical Development
      • Medical Devices & IVDs
      • Digital Health & SaMD
      • AI in Regulated Life Sciences
      • Due Diligence
      • Entry into Europe
      • Food & Cosmetics → nutracompliance.com

      Keep Your Drug-Device Combination Products Variation-Ready

      We’ve experienced, that even long established drug–device combinations can fall short of current regulatory data expectations—putting variations at risk. We support you in assessing and strengthening your DDC data package to ensure robust, compliant submissions.

      DDC Variation Readiness

      EU Submission Readiness for Global Pharma

      Avoid Late Surprises in Your EU Submission. FDA approval is not a guarantee of EU readiness. European regulators apply different expectations for data, documentation, and operational infrastructure. Many US companies encounter gaps that lead to delays, rework, or regulatory friction.

      EU Readiness Checks

      SPOTLIGHT: EU AI Act Q&A Competition

      From May to June 2026, we are hosting the first competition to assess the ability of AI agents to answer truthfully, concisely, and effectively to questions of the AI Act.

      AI Act Competition
  • Resources
  • About
    • Who We Are
    • regulanet®
    • Careers
    • Global
    • UK
    • Ireland
    • Portugal
  • Contact

We're here to help answer any questions you might have.
We look forward to hearing from you.

regenold GmbH
Arrange a Call

Headquarters:
regenold GmbH
Zöllinplatz 4
79410 Badenweiler
Germany

Phone: +49 7632 82 26-0
Email: info@regenold.com

  1. Home
  2. About
  3. regulanet®

regulanet®

icon

When a project needs specific regional expertise and knowledge, we leverage regulanet®.

Development, regulatory, and market access requirements around the world are constantly evolving and growing in complexity. At the same time, development programs are becoming increasingly more global; in-depth knowledge of multiple regions is key to success. We meet this need for specialist expertise around the globe by leveraging our exclusive and long-established platform of trusted experts: regulanet®.

We founded regulanet® in 2001. It brings together independent development, regulatory, and market access experts in more than 90 countries worldwide, working to a common set of standards. When it makes sense for your project, a regenold project lead ensures that your project is supported by the right mix of global and regional experts, driving it forward efficiently. Wherever local expertise is needed, it is delivered through that single accountability line.

Sometimes it makes more sense for clients to work directly with one of our regulanet® partners. In those cases, we refer you to the partner best suited to your needs.

The Right Experts, Consistent Standards

We understand that in an ever more complex development, regulatory, or market access environment, having the right expertise and knowledge across different regions plays a critical role in the success of our client's development programs. Our regulanet® partners have hands-on regional knowledge, they have long-standing and impactful relationships with health authorities, and they can provide agile and flexible resource at the time the project requires them. Alongside this, as a result of our longstanding partnership, our regulanet partners are always at the ready to integrate seamlessly into the project team.

regulanet® is structured to make that seamless and timely integration possible. We work to a common set of standards on communication, documentation, project handover, regulatory writing conventions, and how to handle authority interactions. Where a project requires qualified partners, we have already qualified them, or we do so before the work starts.

The partners themselves are experts we have worked with for years, often across many projects. When we bring in an expert to work on a project, we already know how they document, how they engage with authorities, and how they integrate with the rest of the team.

How We Leverage regulanet®

No two projects are the same. Each one involves a different set of countries or regulatory jurisdictions, a different mix of expertise, a different timeline, and often a different starting point.

regulanet® allows us to work with this kind of variety. For some projects, a regenold project lead provides leadership and a single and accountable point of contact for our clients. The project lead is accountable for the contract, the timeline, and for bringing together the right experts to support the project, working in partnership with regulanet® experts as required. If you are looking for support in a specific region or area of expertise, we also offer the flexibility to make a direct connection with the regulanet® partner.

We maintain and manage regulanet®; we have a longstanding partnership, working relationship and most importantly trust with all of our regulanet® partners. We understand which of our partners has the regional expertise and knowledge to solve a specific problem or task, and we can seamlessly include the right experts in your projects. Whether we lead, refer, or run a project together, you get one coordinated solution.

Why We Built regulanet®

regenold was founded in 1994, just as the European Mutual Recognition Procedure and the centralised procedure were starting to operate. From the very beginning, our work involved getting products approved across multiple European markets at once, and we understood early on that this needed a broad team to do well. Each country has its own authority, its own interpretation of international guidelines, and its own way of handling the national steps in international procedures.

By the late 1990s, we were running enough international procedures to know what we needed: experts on the ground in each relevant country, working with their authority every day, in the local language. We started building those relationships, and in 2001 that work became regulanet®.

Twenty-five years later, international and global procedures remain a core part of what we do, and regulanet® provides the regional expertise and global reach we need to execute them well. Today, regulanet® covers North America, the major Asian, Latin American, Middle Eastern, and African markets, and Europe. The model has supported thousands of national filings in time-critical settings, where hands-on local expertise made the difference between a project being successful or not.

What regulanet® Covers

Across more than 90 countries, regulanet® covers the work your project needs at every stage of a product's life.

Development

  • Contract research and clinical investigational sites
  • Contract development and manufacturing
  • Analytical, bioanalytical, and pharmacokinetic / pharmacodynamic modelling

Regulatory Affairs

  • National marketing authorisation procedures and variations
  • Lifecycle and post-approval activities
  • Local product information, labelling, and translations
  • National pharmacovigilance and QPPV functions
  • Local clinical trial applications

Market Access and Reimbursement

  • Country-specific reimbursement strategy and submissions
  • Health economics and HTA support
  • Compliance with national pricing and access requirements

AI and digital expertise runs across all three. Regulanet® partners include specialists in AI implementation, validation, vendor qualification, and the practical use of AI systems in regulated work.

We lead, the right experts are brought in for the specific work, and that work is integrated into your overall project.

Page Contents

  • The Right Experts, Consistent Standards
  • How We Leverage regulanet®
  • Why We Built regulanet®
  • What regulanet® Covers

Get in Touch

Tell us where your product needs to be approved. We will outline how regenold and regulanet® would work together on your project. To browse the network directly, see regulanet.com.

Get in Touch
regenold GmbH

regenold is a global, end-to-end integrated development partner for pharmaceuticals, medical devices, and drug-device combination products. We support life sciences companies across the entire product lifecycle, delivering integrated development, regulatory, and market access expertise to enable efficient, compliant advancement from concept to market.

Follow us on LinkedIn!

regenold GmbH
Zöllinplatz 4
79410 Badenweiler
Germany

Phone: +49 7632 82 26-0
Email: info@regenold.com

© 2026 regenold GmbH. All Rights Reserved. • Impressum/Legal Notice • Datenschutzerklärung • Privacy Policy •